–
Aardvark Therapeutics, Inc.
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY22 – FY25
(positive)
millions USD
FY22:
FY23:
–
FY24:
0
FY25:
–
(positive)
Change from FY22 to FY25
millions USD
FY22:
−10.4
FY23:
−7.42
FY24:
−22.8
FY25:
−62.7
(positive)
millions USD
FY22:
–
FY23:
–
FY24:
–
FY25:
−62.7
(positive)
millions USD
FY22:
–
FY23:
–
FY24:
–
FY25:
−57.6
(positive)
Change from FY22 to FY25
millions USD
FY22:
−13.6
FY23:
−7.21
FY24:
−20.6
FY25:
−57.6
All amounts in millions USD FY22, FY23: figures supplemented from Twelve Data because the SEC filings do not reach back this far.